Literature DB >> 3670972

Buffy coat transfusions in neutropenic neonates with presumed sepsis: a prospective, randomized trial.

J E Baley1, E K Stork, P I Warkentin, S B Shurin.   

Abstract

Neonatal sepsis, accompanied by neutropenia, is associated with a high mortality. To determine whether granulocyte transfusions improve the survival of critically ill neutropenic infants, we prospectively randomized 25 infants to transfusion and nontransfusion groups, matching for birth weight (less than or equal to 1,500 g or greater than 1,500 g). Infants with necrotizing enterocolitis were randomized separately. Neutropenia was established by two successive absolute neutrophil counts less than or equal to 1,500 cells prior to randomization. The transfusion (n = 12) and nontransfusion (n = 13) groups did not differ with respect to clinical or hematologic characteristics. In 23 of 25, bone marrow aspirations were performed to determine the percentage of neutrophil storage pool. Granulocyte transfusions of buffy coats from single units of whole blood (0.1 to 0.9 X 10(9) polymorphonuclear leukocytes per kilogram) were given daily until the absolute neutrophil count increased to more than 1,500/microL. Only five infants, mostly those with necrotizing enterocolitis, required more than one transfusion. A circulating immature to total neutrophil ratio (I:T) greater than or equal to 0.80 was not predictive of an infant with a neutrophil storage pool less than or equal to 7%, and neither an I:T less than 0.80 nor a neutrophil storage pool greater than 7% were predictive of survival. Granulocyte transfusions did not improve survival when either comparing the whole group, those 17 infants with cultures positive for bacteria or viruses, the 19 infants with a circulating I:T greater than or equal to 0.80, or the nine infants with a neutrophil storage pool less than or equal to 7%.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1987        PMID: 3670972

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  8 in total

1.  Granulocyte macrophage-colony stimulating factor (GM-CSF) in neonatal neutropenia.

Authors:  M Ray; K Mukhopadhyay; A Narang
Journal:  Indian J Pediatr       Date:  2000-01       Impact factor: 1.967

2.  Exchange transfusion: evaluating the use of a mixture of citrated red cells and heparinized plasma.

Authors:  W J Valk; K D Liem; B A van Dijk
Journal:  Eur J Pediatr       Date:  1992-11       Impact factor: 3.183

Review 3.  Neonatal septicemia.

Authors:  A C Kuruvilla
Journal:  Indian J Pediatr       Date:  1988 Mar-Apr       Impact factor: 1.967

Review 4.  Granulocyte transfusions for neonates with confirmed or suspected sepsis and neutropenia.

Authors:  Mohan Pammi; Peter Brocklehurst
Journal:  Cochrane Database Syst Rev       Date:  2011-10-05

5.  Decreased plasma fibronectin concentrations in preterm infants with septicaemia.

Authors:  M P Dyke; K D Forsyth
Journal:  Arch Dis Child       Date:  1993-05       Impact factor: 3.791

Review 6.  New modalities for treating neonatal infection.

Authors:  A R Bedford-Russell
Journal:  Eur J Pediatr       Date:  1996-08       Impact factor: 3.183

Review 7.  Granulocyte transfusions for preventing infections in people with neutropenia or neutrophil dysfunction.

Authors:  Lise J Estcourt; Simon Stanworth; Carolyn Doree; Patricia Blanco; Sally Hopewell; Marialena Trivella; Edwin Massey
Journal:  Cochrane Database Syst Rev       Date:  2015-06-29

8.  Neonatal sepsis: a systematic review of core outcomes from randomised clinical trials.

Authors:  Cían J Henry; Gergana Semova; Ellen Barnes; Isabel Cotter; Tara Devers; Aisyah Rafaee; Andreea Slavescu; Niamh O Cathain; Danielle McCollum; Edna Roche; David Mockler; John Allen; Judith Meehan; Claus Klingenberg; Jos M Latour; Agnes van den Hoogen; Tobias Strunk; Eric Giannoni; Luregn J Schlapbach; Marina Degtyareva; Frans B Plötz; Willem P de Boode; Lars Naver; James L Wynn; Helmut Küster; Jan Janota; Fleur M Keij; Irwin K M Reiss; Joseph M Bliss; Richard Polin; Joyce M Koenig; Mark A Turner; Christopher Gale; Eleanor J Molloy
Journal:  Pediatr Res       Date:  2022-01-07       Impact factor: 3.953

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.